|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.39 USD | +4.81% |
|
+9.61% | +4.63% |
| 31/07 | Atricure Insider Sold Shares Worth $946,000, According to a Recent SEC Filing | MT |
| 28/07 | UBS Adjusts Price Target on AtriCure to $50 From $55, Maintains Buy Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ATRICURE, INC. | Other Medical Equipment, Supplies & Distribution | +4.81% | +9.61% | +4.63% | +17.22% | -47.61% | 210.54Cr |
- Stock Market
- Stocks
- ATRC Stock
- Charts AtriCure, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
















